🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Lacosamide Krka 200 mg film-coated tablets
PA1347/099/004
Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 50 mg film-coated tablets
PA1347/099/001
Lacosamide KRKA, d.d., Novo mesto Marketed
Lansoprazole Krka 15 mg Gastro-resistant Capsules, hard
PA1347/062/001
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard
PA1347/062/002
Lansoprazole KRKA, d.d., Novo mesto Marketed
Lenalidomide Krka 10 mg hard capsules
EU/1/20/1519/007-008
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 15 mg hard capsules
EU/1/20/1519/009-010
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 2.5 mg hard capsules
EU/1/20/1519/001-002
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 20 mg hard capsules
EU/1/20/1519/011-012
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 25 mg hard capsules
EU/1/20/1519/013-014
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 5 mg hard capsules
EU/1/20/1519/003-004
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Lenalidomide Krka 7.5 mg hard capsules
EU/1/20/1519/005-006
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
Levocetirizine Krka 5mg film-coated tablets
PA1347/043/001
Levocetirizine dihydrochloride KRKA, d.d., Novo mesto Marketed
Levofloxacin Krka 250 mg film-coated tablets
PA1347/048/001
Levofloxacin KRKA, d.d., Novo mesto Marketed
Levofloxacin Krka 500 mg film-coated tablets
PA1347/048/002
Levofloxacin KRKA, d.d., Novo mesto Marketed
Linagliptin Krka 5 mg film-coated tablets
PA1347/120/001
Linagliptin KRKA, d.d., Novo mesto Not marketed
Linezolid 2 mg/ml solution for infusion
PA1347/057/002
Linezolid KRKA, d.d., Novo mesto Marketed
Linezolid Krka 600 mg film-coated tablets
PA1347/057/001
Linezolid KRKA, d.d., Novo mesto Marketed
Losartan Krka 100 mg film-coated tablets
PA1347/020/003
Losartan potassium KRKA, d.d., Novo mesto Marketed
Losartan Krka 25 mg film-coated tablets
PA1347/020/001
Losartan potassium KRKA, d.d., Novo mesto Not marketed
Losartan Krka 50 mg film-coated tablets
PA1347/020/002
Losartan potassium KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/12.5 mg film-coated tablets
PA1347/040/002
Losartan potassium, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 100 mg/25 mg film-coated tablets
PA1347/040/003
Losartan potassium, Hydrocholothiazide KRKA, d.d., Novo mesto Marketed
Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg film-coated tablets
PA1347/040/001
Losartan potassium, Hydrochlorothiazide KRKA, d.d., Novo mesto Marketed
Loxentia 20mg hard gastro-resistant capsule
PA1347/051/001
Duloxetine KRKA, d.d., Novo mesto Marketed
Loxentia 40mg hard gastro-resistant capsule
PA1347/051/003
Duloxetine KRKA, d.d., Novo mesto Marketed
Marixino 10 mg film-coated tablets
EU/1/13/820/001-013
Memantine hydrochloride KRKA, d.d., Novo mesto
Marixino 20 mg film-coated tablets
EU/1/13/820/014-026
Memantine hydrochloride KRKA, d.d., Novo mesto
Montelukast 10 mg film-coated tablets
PA1347/039/003
Montelukast KRKA, d.d., Novo mesto Marketed
Montelukast 4 mg chewable tablets
PA1347/039/001
Montelukast KRKA, d.d., Novo mesto Marketed
Montelukast 5 mg chewable tablets
PA1347/039/002
Montelukast KRKA, d.d., Novo mesto Marketed
Nimvastid 1.5 mg hard capsules
EU/1/09/525/1-7
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 1.5 mg orodispersible tablets
EU/1/09/525/26-31
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 3 mg hard capsules
EU/1/09/525/008-013
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 3 mg orodispersible tablets
EU/1/09/525/32-36
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 4.5 mg hard capsules
EU/1/09/525/14-19
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 4.5 mg orodispersible tablets
EU/1/09/525/37-41
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 6 mg hard capsules
EU/1/09/525/20-25
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nimvastid 6 mg orodispersible tablets
EU/1/09/525/42-46
Rivastigmine hydrogen tartrate KRKA, d.d., Novo mesto
Nolpacid 20 mg gastro-resistant tablets
PA1347/032/001
Pantoprazole KRKA, d.d., Novo mesto Not marketed
Nolpaza 20 mg gastro-resistant tablets
PA1347/006/001
Pantoprazole KRKA, d.d., Novo mesto Marketed
Nolpaza 40 mg gastro-resistant tablets
PA1347/006/002
Pantoprazole KRKA, d.d., Novo mesto Marketed
Nolxado 10 mg/5 mg prolonged-release tablets
PA1347/085/001
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate KRKA, d.d., Novo mesto Not marketed
Nolxado 20 mg/10 mg prolonged-release tablets
PA1347/085/002
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate KRKA, d.d., Novo mesto Not marketed
Nolxado 40 mg/20 mg prolonged-release tablets
PA1347/085/003
OXYCODONE HYDROCHLORIDE, Naloxone hydrochloride dihydrate KRKA, d.d., Novo mesto Not marketed
Olmesartan Krka 10 mg film-coated tablets
PA1347/060/001
Olmesartan medoxomil KRKA, d.d., Novo mesto Marketed
Olmesartan Krka 20 mg film-coated tablets
PA1347/060/002
Olmesartan medoxomil KRKA, d.d., Novo mesto Marketed
Olmesartan Krka 40 mg film-coated tablets
PA1347/060/003
Olmesartan medoxomil KRKA, d.d., Novo mesto Marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/10 mg/25 mg film-coated tablets
PA1347/096/005
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/5 mg/12.5 mg film-coated tablets
PA1347/096/002
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Krka 40 mg/5 mg/25 mg film-coated tablets
PA1347/096/003
Olmesartan medoxomil, Amlodipine, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
1 2 3 4 5 6 7

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.